Literature DB >> 22791597

Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

A Gentry-Maharaj1, A Sharma, M Burnell, A Ryan, N N Amso, M W Seif, G Turner, C Brunell, G Fletcher, R Rangar, L Fallowfield, S Campbell, I Jacobs, U Menon.   

Abstract

OBJECTIVE: To assess pain and overall experience of transvaginal sonography (TVS) in asymptomatic postmenopausal women.
METHODS: In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), 50 639 postmenopausal women were randomized to undergo annual TVS at 13 trial centers in England, Wales and Northern Ireland. Together with the appointment letter for their annual scan, a random sample of 150 women per center was sent a detailed 48-item postal questionnaire regarding the screening experience. It included a specific question about pain using a score of 0-5, where 5 was severe pain and 3 was discomfort. To assess factors that might affect a woman's reported pain experience, the pain score was regressed on age, hormone replacement therapy use, body mass index, a history of hysterectomy, prolonged scanning time, ovarian visualization, scan result, sonographer's visualization rates and opinion of the women regarding the sonographer who performed the scan.
RESULTS: Between 7 July and 9 September 2009, 1950 randomly chosen women (150 per regional center) were sent the questionnaire. Of the 800 (41.0%) who returned the questionnaire, 651 could be linked to their TVS appointment. One-hundred and fifty-two (23.3%) women reported pain/discomfort (score 3-5) during TVS and 473 (72.7%) reported no discomfort (score 0-2). Only 23 (3.5%) women reported experiencing moderate/severe pain. Increasing discomfort/pain was independently associated with a history of hysterectomy and participant's reporting of prolonged scan time. Women who experienced pain on TVS were less compliant (odds ratio = 0.87) with the following year's scan compared with those who did not experience pain.
CONCLUSIONS: The majority of postmenopausal women found TVS acceptable. Pain influenced compliance and correlated with women's perception of increased scanning time and previous hysterectomy.
Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22791597     DOI: 10.1002/uog.12262

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  5 in total

Review 1.  Dangers in the dark: Calling for a safer practice of transvaginal ultrasonography.

Authors:  Kelly Collins; Tina Hamlyn; George Bruxner; Alka Kothari
Journal:  Australas J Ultrasound Med       Date:  2020-12-05

2.  Risk of Incident Coronary Heart Disease Events in Men Compared to Women by Menopause Type and Race.

Authors:  Catherine Kim; Mary Cushman; Yulia Khodneva; Lynda D Lisabeth; Suzanne Judd; Dawn O Kleindorfer; Virginia J Howard; Monika M Safford
Journal:  J Am Heart Assoc       Date:  2015-07-01       Impact factor: 5.501

3.  Transvaginal Sonography: perception and attitude of Nigerian women.

Authors:  Mark C Okeji; Kennedy K Agwuna; Chika N Ihudiebube-Splendor; Iliyasu Y Izge; Kelechi K Ekuma; Jennifer O Emeter
Journal:  BMC Womens Health       Date:  2017-07-27       Impact factor: 2.809

4.  Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening.

Authors:  Valerie Jenkins; Lesley Fallowfield; Carolyn Langridge; Jessica Barrett; Andy Ryan; Ian Jacobs; Justine Kilkerr; Usha Menon; Vernon Farewell
Journal:  Int J Gynecol Cancer       Date:  2015-10       Impact factor: 3.437

5.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Authors:  Ian J Jacobs; Usha Menon; Andy Ryan; Aleksandra Gentry-Maharaj; Matthew Burnell; Jatinderpal K Kalsi; Nazar N Amso; Sophia Apostolidou; Elizabeth Benjamin; Derek Cruickshank; Danielle N Crump; Susan K Davies; Anne Dawnay; Stephen Dobbs; Gwendolen Fletcher; Jeremy Ford; Keith Godfrey; Richard Gunu; Mariam Habib; Rachel Hallett; Jonathan Herod; Howard Jenkins; Chloe Karpinskyj; Simon Leeson; Sara J Lewis; William R Liston; Alberto Lopes; Tim Mould; John Murdoch; David Oram; Dustin J Rabideau; Karina Reynolds; Ian Scott; Mourad W Seif; Aarti Sharma; Naveena Singh; Julie Taylor; Fiona Warburton; Martin Widschwendter; Karin Williamson; Robert Woolas; Lesley Fallowfield; Alistair J McGuire; Stuart Campbell; Mahesh Parmar; Steven J Skates
Journal:  Lancet       Date:  2015-12-17       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.